| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |